Users Discontinuing Weight-Loss Jabs Put On Weight Far More Rapidly Than Those on Conventional Diets

Fresh analysis reveals that people who come off blockbuster slimming jabs like Mounjaro or Wegovy tend to recover reduced body mass far faster than those who halt traditional diet and exercise plans.

Research printed in a leading medical journal points out that while overweight individuals frequently drop substantial amounts of their total mass while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.

"Users purchasing these drugs should be cognizant of the danger of fast rebound weight gain when the therapy concludes," stated researcher Dr. Susan Jebb.

Such speed of recovery means a reversion to original mass in about a year and a half.

Analyzing Treatments

The research, which looked at dozens of studies involving over 9,000 of patients, contrasted the effects of GLP-1 agonists with other pills.

The team note that individuals who shed pounds through lifestyle changes alone generally have a less rapid weight regain—perhaps 0.1 kg a month—after stopping.

Understanding the Quick Rebound

Experts propose the way of the injections is key to understanding the amplified rebound.

These medications copy a natural hormone called GLP-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone concentrations several times higher than normal might result in the body to produce less of its endogenous hormone, and could reduce sensitivity to its actions," explained Dr. Adam Collins, a dietetics expert.

"Discontinuation of this GLP-1 'fix' means appetite is uncontrolled, making binge eating much more probable."

An Ongoing Condition?

Medical guidelines suggest the injections for individuals with obesity-related health risks, alongside prescribed diet and exercise modifications.

Professionals argue that, due to the significant potential of weight regain, the therapy should be considered ongoing.

This opinion is echoed by drug manufacturers, who say that the results "highlight the long-term character of obesity," akin to managing conditions like diabetes.

Patient Accounts

People who have discontinued the medication describe a sudden return of cravings.

"It was like something that goes on and you're instantly ravenous," recalled an individual.

This challenge is worsened if individuals have not established permanent dietary or behavioural changes during treatment.

Growing Use

Figures indicate that millions of people in the UK have used these injections in the last 12 months, with desire being substantial.

• Use is more common among females than men.
• The middle-aged demographic shows the greatest usage rates.
• Many access the medications through private healthcare rather than the NHS.

Finally, clinicians stress that while GLP-1 drugs are potent agents for weight loss, they are not a standalone fix and maintained weight loss relies on integrated lifestyle changes.